OTCMKTS:VXRT

Vaxart (VXRT) Stock Price, News & Analysis

Vaxart logo
$0.36 0.00 (0.00%)
As of 03:59 PM Eastern

About Vaxart Stock (OTCMKTS:VXRT)

Advanced

Key Stats

Today's Range
$0.35
▼
$0.37
50-Day Range
$0.36
▼
$0.50
52-Week Range
$0.33
▼
$0.84
Volume
245,774 shs
Average Volume
297,552 shs
Market Capitalization
$86.51 million
P/E Ratio
2.73
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Vaxart, Inc. is a clinical-stage biotechnology company developing oral vaccines for infectious diseases. Its proprietary platform is designed to deliver vaccine candidates in tablet form and to stimulate immune responses at mucosal surfaces as well as throughout the body.

The company’s investigational programs have included vaccines for norovirus, seasonal influenza and COVID-19. These candidates remain in development and are not approved vaccines.

Based in South San Francisco, California, Vaxart focuses on research and development and may work with external partners to advance its vaccine programs.

AI Generated. May Contain Errors.

Vaxart Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

VXRT MarketRank™: 
1.13172920065 of 5 stars

Vaxart scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vaxart has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Vaxart has received no research coverage in the past 90 days.

  • Read more about Vaxart's stock forecast and price target.
  • Earnings Growth

    Earnings for Vaxart are expected to decrease in the coming year, from ($0.68) to ($1.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaxart is 2.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.33.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaxart is 2.73, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.19.

  • Price to Book Value per Share Ratio

    Vaxart has a P/B Ratio of 1.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.02% of the float of Vaxart has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaxart has a short interest ratio ("days to cover") of 3.95, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaxart has recently increased by 0.54%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Vaxart does not currently pay a dividend.

  • Dividend Growth

    Vaxart does not have a long track record of dividend growth.

  • News Sentiment

    Vaxart has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vaxart this week, compared to 1 article on an average week.
  • Search Interest

    Only 3 people have searched for VXRT on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Vaxart to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaxart insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.80% of the stock of Vaxart is held by insiders.

  • Percentage Held by Institutions

    18.05% of the stock of Vaxart is held by institutions.

  • Read more about Vaxart's insider trading history.
Receive VXRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaxart and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VXRT Stock News Headlines

You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
See More Headlines

VXRT Stock Analysis - Frequently Asked Questions

Vaxart's stock was trading at $0.3464 at the beginning of 2026. Since then, VXRT shares have increased by 2.5% and is now trading at $0.3550.

Vaxart, Inc. (OTCMKTS:VXRT) released its earnings results on Thursday, November, 5th. The biotechnology company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.04. The biotechnology company earned $10.62 million during the quarter, compared to the consensus estimate of $27.20 million. Vaxart had a net margin of 16.02% and a trailing twelve-month return on equity of 35.14%.
Read the conference call transcript
.

Vaxart shares reverse split before market open on Wednesday, February 14th 2018.The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

Shares of VXRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaxart investors own include Inovio Pharmaceuticals (INO), Moderna (MRNA), Sorrento Therapeutics (SRNE), Novavax (NVAX), NIO (NIO), Tesla (TSLA) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/05/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:VXRT
Previous Symbol
NASDAQ:NABI
CIK
72444
Employees
65
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
$0.13
Trailing P/E Ratio
2.73
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$16.33 million
Net Margins
16.02%
Pretax Margin
16.42%
Return on Equity
35.14%
Return on Assets
17.10%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.71
Quick Ratio
1.71

Sales & Book Value

Annual Sales
$237.26 million
Price / Sales
0.36
Cash Flow
$0.10 per share
Price / Cash Flow
3.47
Book Value
$0.27 per share
Price / Book
1.31

Miscellaneous

Outstanding Shares
243,700,000
Free Float
236,879,000
Market Cap
$86.51 million
Optionable
No Data
Beta
1.15

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (OTCMKTS:VXRT) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners